2017-02-09 / Around Town

New Board Chair is Appointed


Dr. Lewis Cantley, Ph.D. Dr. Lewis Cantley, Ph.D. Hope Funds for Cancer Research, dedicated to advancing innovative research for the most difficult-to-treat cancers, has announced Lewis Cantley, Ph.D., has been elected as the fourth chairman of its board of trustees.

“Dr. Cantley is an outstanding choice to lead the Hope Funds for Cancer Research board of trustees,” said Leah Rush Cann, a Hope Funds founder and chair of its executive committee. “His achievements in basic and clinical science along with his expertise in mentoring young scientists make him ideally suited for the role. He has known the organization as a mentor, speaker, and honoree and now can combine those experiences to lead Hope Funds for Cancer Research into its next decade.”

Cantley is currently the Meyer Director of the Sandra and Edward Meyer Cancer Center and a professor of cancer biology in medicine at Weill Cornell Medicine in New York City. He was formerly a professor in the Departments of Systems Biology and Medicine at Harvard Medical School, and the Director of Cancer Research at the Beth Israel Deaconess Medical Center in Boston. In 1985, Cantley and colleagues made the seminal discovery of the existence of phosphoinositide 3-kinase (PI3K). The discovery of PI-3-Kinase and its role in cancer metabolism led to Cantley being an inaugural recipient of the Breakthrough Prize in Life Sciences.

Cantley received his undergraduate degree summa cum laude in chemistry from Wesleyan College and his Ph.D. from Cornell University. He was a postdoctoral fellow at Harvard University. In 1978, Cantley became assistant professor of biochemistry and molecular biology at Harvard. In 1985, he became a full professor in physiology at Tufts University School of Medicine.

Hope Funds for Cancer Research is dedicated to finding cancer discoveries by funding outstanding young cancer researchers. The organization was formed in 2006 to establish a philanthropic vehicle that would take a rational scientific, medical, and investment approach to making grants for the most innovative and promising research efforts to address the most difficult-to-treat cancers. Its administrative office is located at 174 Bellevue Ave.

For more information visit hopefunds.org or call 401-847-3286.

Return to top